- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment Options for COVID-19: A Review
Authors
Keywords
-
Journal
Frontiers in Medicine
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-07-31
DOI
10.3389/fmed.2020.00480
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
- (2020) Qiurong Ruan et al. INTENSIVE CARE MEDICINE
- Anti-HCV, nucleotide inhibitors, repurposing against COVID-19
- (2020) Abdo A. Elfiky LIFE SCIENCES
- First Case of 2019 Novel Coronavirus in the United States
- (2020) Michelle L. Holshue et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnosis and treatment of 2019 novel coronavirus infection in children: a pressing issue
- (2020) Kun-Ling Shen et al. World Journal of Pediatrics
- Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies
- (2020) Syed Faraz Ahmed et al. Viruses-Basel
- Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
- (2020) Timothy P. Sheahan et al. Nature Communications
- Rapid and severe Covid‐19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab
- (2020) Gonzalo De Luna et al. AMERICAN JOURNAL OF HEMATOLOGY
- Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report
- (2020) J.-M. Michot et al. ANNALS OF ONCOLOGY
- Effectiveness of glucocorticoid therapy in patients with severe coronavirus disease 2019
- (2020) Yuan-Yuan Qin et al. CHINESE MEDICAL JOURNAL
- Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019
- (2020) Yan-Ming Zeng et al. CHINESE MEDICAL JOURNAL
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Xueting Yao et al. CLINICAL INFECTIOUS DISEASES
- Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019‐nCoV Infection
- (2020) Yin‐Xiao Du et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection
- (2020) Jacques Fantini et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
- (2020) Chi Zhang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients?
- (2020) Samir Jawhara INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Convalescent Plasma to Treat COVID-19
- (2020) John D. Roback et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
- (2020) Chenguang Shen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Tocilizumab treatment in COVID-19: A single center experience
- (2020) Pan Luo et al. JOURNAL OF MEDICAL VIROLOGY
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
- (2020) Shibo Jiang et al. TRENDS IN IMMUNOLOGY
- Macrolide treatment for COVID-19: Will this be the way forward?
- (2020) Masashi Ohe et al. BioScience Trends
- Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
- (2020) Jianjun Gao et al. BioScience Trends
- Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment
- (2020) Zhenwei Wang et al. BioScience Trends
- Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients
- (2020) Yonggang Zhou et al. National Science Review
- The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
- (2020) Leon Caly et al. ANTIVIRAL RESEARCH
- Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
- (2020) Ka-Tim Choy et al. ANTIVIRAL RESEARCH
- Type 1 interferons as a potential treatment against COVID-19
- (2020) Erwan Sallard et al. ANTIVIRAL RESEARCH
- Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?
- (2020) Bingwen Liu et al. JOURNAL OF AUTOIMMUNITY
- Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study
- (2020) Abdo A. Elfiky LIFE SCIENCES
- Broad-spectrum coronavirus antiviral drug discovery
- (2019) Allison L. Totura et al. Expert Opinion on Drug Discovery
- Reevaluation of the efficacy of favipiravir against rabies virus using in vivo imaging analysis
- (2019) Kentaro Yamada et al. ANTIVIRAL RESEARCH
- Clinical outcomes of current medical approaches for Middle East respiratory syndrome: A systematic review and meta-analysis
- (2018) Mostafa Ebraheem Morra et al. REVIEWS IN MEDICAL VIROLOGY
- Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
- (2018) Maria L. Agostini et al. mBio
- IVIG-mediated effector functions in autoimmune and inflammatory diseases
- (2017) Caroline Galeotti et al. INTERNATIONAL IMMUNOLOGY
- Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
- (2017) Yousuke FURUTA et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
- (2017) Rudragouda Channappanavar et al. Seminars in Immunopathology
- Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
- (2016) Travis K. Warren et al. NATURE
- Lopinavir/ritonavir in the treatment of HIV-1 infection: a review
- (2016) Jonathan Shuter Therapeutics and Clinical Risk Management
- Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome: a case report
- (2015) Uh Jin Kim et al. ANTIVIRAL THERAPY
- Chloroquine inhibited Ebola virus replication in vitro but failed to protect against infection and disease in the in vivo guinea pig model
- (2015) Stuart D. Dowall et al. JOURNAL OF GENERAL VIROLOGY
- Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset
- (2015) Jasper Fuk-Woo Chan et al. JOURNAL OF INFECTIOUS DISEASES
- Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture
- (2014) Adriaan H. de Wilde et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model
- (2014) Lisa Oestereich et al. ANTIVIRAL RESEARCH
- Ribavirin and interferon (IFN)-alpha-2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus (MERS-CoV): a preliminary report of two cases
- (2014) Mohammed Khalid et al. ANTIVIRAL THERAPY
- Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen
- (2014) Nikolaos Spanakis et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study
- (2014) Ali S Omrani et al. LANCET INFECTIOUS DISEASES
- Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients
- (2014) J.R. Marcelin et al. Transplant Infectious Disease
- Nuclear localization of dengue virus (DENV) 1–4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin
- (2013) M.Y.F. Tay et al. ANTIVIRAL RESEARCH
- T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 Viruses In Vitro
- (2013) T. Baranovich et al. JOURNAL OF VIROLOGY
- Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV–infected rhesus macaques
- (2013) Darryl Falzarano et al. NATURE MEDICINE
- Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin
- (2013) Darryl Falzarano et al. Scientific Reports
- Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus
- (2012) Kylie M. Wagstaff et al. BIOCHEMICAL JOURNAL
- Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug
- (2012) E. Mastrangelo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Macrolide Therapy in Respiratory Viral Infections
- (2012) Jin-Young Min et al. MEDIATORS OF INFLAMMATION
- Correction: A Randomized Controlled Trial of Chloroquine for the Treatment of Dengue in Vietnamese Adults
- (2012) Vianney Tricou et al. PLoS Neglected Tropical Diseases
- Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy
- (2011) S. V. Kaveri et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trial
- (2011) Nicholas I Paton et al. LANCET INFECTIOUS DISEASES
- Cytokine Responses in Porcine Respiratory Coronavirus-Infected Pigs Treated with Corticosteroids as a Model for Severe Acute Respiratory Syndrome
- (2008) X. Zhang et al. JOURNAL OF VIROLOGY
- On Chikungunya Acute Infection and Chloroquine Treatment
- (2008) Xavier De Lamballerie et al. VECTOR-BORNE AND ZOONOTIC DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More